Syzygium Schwabe

These products are for targeted treatment of specific indications.
The preparations´ claims of indication result from the respective homeopathic drug pictures and the clinical application of the active substances. Each active substance is a proven reasonable part of the combination as it contributes to the positive appraisal of the finished product enhancing the synergistic effect with regard to the indication. The basis of this evaluation is the homeopathic literature in general, specifically the Materiae Medicae, providing descriptions of the single remedies, their field of action, the symptoms reported in drug provings and their clinical application.
Dr. Willmar Schwabe Pharmaceuticals provided a series of complex medicines already in 1925. By 1940 Schwabe Pharmaceuticals provided its own complex medicines.
Since then the products are part of Schwabe´s success story.

Syzygium Schwabe